Weichang Zhou
Chief Technology Officer (CTO), Executive Director of the Board, Executive Vice President , WuXi Biologics
7th International Conference on Accelerating Biopharmaceutical Development (AccBio 2021)
March 8, 2021 to March 10, 2021
The need to rapidly develop and commercialize therapeutics to fight COVID-19 has highlighted the importance of accelerating manufacturing development, and there are opportunities for the industry to carry...
Sponsors
Featured Speakers & Events
-
-
Jessica Phillips
Site Head, Indianapolis Device Manufacturing, Eli Lilly and Company -
Alina Baum
Senior Staff Scientist , Regeneron Pharmaceuticals -
Peter Marks
Director, Center for Biologics Evaluation and Research (CBER), FDA -
Julie Gerberding
Executive Vice President and Chief Patient Officer , Merck & Co., Inc. -
Michael Ku
Vice President, Global Clinical Supply (GCS) , Pfizer -
Natalie Christian
Executive Director, Global Vaccine and Biologics Commercialization , Merck -
Ranga Godavarti
Vice President, Bioprocess Research and Development, Pfizer -
Douglas Miller
Managing Director, BioProcess Technology Group, BDO -
Tongtong Wang
VP, Head of Technical Development US Biologics, Genentech -
Shawn Lawrence
Biochemical Engineer , Regeneron Pharmaceuticals, Inc. -
Stephen Hardt
Vice President Supply Chain and External Manufacturing, Allogene Therapeutics -
Brian Kelley
Senior Vice President of Process Development and Manufacturing, VIR Biotechnology -
Paul Lewus
Executive Director, Plant Manager, Amgen -
Nandu Budigi
Director of R&D, Tychan Pte Ltd
Session Topics
Top Reasons to Attend
- Benefit from lessons learned from the pandemic
- Meet speakers from companies on the forefront of COVID-19 therapies as well as key regulators from the FDA
- Learn about post-pandemic opportunities
- Hear keynote presentations from thought leaders
- Explore all aspects of bio therapeutic development from early development to launch, regulatory to supply chain, mAB to gene therapy